Pediatrix. (MD) Reports Q1 EPS Beat

On May 5, 2026, Pediatrix Medical Group, Inc. (NYSE:MD) reported Q1 adjusted EPS of 44c, versus the statement estimation of 38c. Revenue totaled $476M, versus the statement estimation of $465.82M. Same-unit gross from nett reimbursement-related factors accrued 4.4% twelvemonth implicit year. CEO Mark Ordan said first-quarter operating results exceeded expectations, driven by top-line growth, portion adding that the company’s priorities for 2026 stay centered connected supporting infirmary partners done quality-focused attraction delivery. Ordan besides said Pediatrix believes its beardown currency travel procreation and equilibrium expanse presumption the institution to prosecute further opportunities moving forward. Pediatrix Medical Group, Inc. (NYSE:MD) reaffirmed its FY26 adjusted EBITDA outlook of $280M-$300M.

On April 20, 2026, Jefferies expert Jack Slevin raised the firm’s terms people connected Pediatrix Medical Group, Inc. (NYSE:MD) to $27 from $24 portion maintaining a Buy rating. The steadfast said caller underperformance crossed healthcare services stocks reflected capitalist concerns tied to Q1 diligent volumes, though Jefferies questioned whether statement expectations afloat accounted for weather-related disruptions caused by wintertime storms successful Southern and East Coast markets.

Samuel Borges Photography/Shutterstock.com

Meanwhile, Truist raised the firm’s terms people connected Pediatrix Medical Group, Inc. (NYSE:MD) to $23 from $21 portion maintaining a Hold standing arsenic portion of a broader preview of healthcare services earnings. Truist said it remains constructive connected the assemblage fixed beardown request trends, supportive reimbursement conditions, antiaircraft characteristics, and continued benefits tied to AI, automation, and connectivity initiatives.

Pediatrix Medical Group, Inc. (NYSE:MD) provides newborn, maternal-fetal, and pediatric subspecialty healthcare services successful the United States.

While we admit the imaginable of MD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.